A little concerning that a quarter of patients discontinued Daybue after 6 months; maybe a future task to fine tune.
- Forums
- ASX - By Stock
- NEU
- Ann: Q4 2023 quarterly activity report
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.20%
!
$12.57

Ann: Q4 2023 quarterly activity report, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.57 |
Change
0.025(0.20%) |
Mkt cap ! $1.559B |
Open | High | Low | Value | Volume |
$12.61 | $12.68 | $12.34 | $1.640M | 131.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 183 | $12.55 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.57 | 33 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 115 | 12.570 |
5 | 633 | 12.560 |
4 | 1320 | 12.550 |
4 | 1348 | 12.540 |
5 | 1336 | 12.530 |
Price($) | Vol. | No. |
---|---|---|
12.600 | 572 | 4 |
12.610 | 4365 | 6 |
12.620 | 1523 | 6 |
12.630 | 1571 | 8 |
12.640 | 4869 | 6 |
Last trade - 10.40am 25/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |